FT.com / Comment / Editorial - Missing links - 0 views
-
Marco Cantamessa on 30 Jul 09A brief editorial comment on the problem of conflicts of interest that emerge between companies that sponsor academic research and the recipients of such grants. Of course, when the field is pharmaceuticals, the problems become very big.